Seres Therapeutics (MCRB)
(Delayed Data from NSDQ)
$1.07 USD
-0.01 (-0.93%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $1.08 +0.01 (0.93%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.30 | 5.88% |
Earnings Summary
For their last quarter, Seres Therapeutics (MCRB) reported earnings of -$0.27 per share, beating the Zacks Consensus Estimate of $-0.36 per share. This reflects a positive earnings surprise of 25.00%. Look out for MCRB's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.30 per share, reflecting a year-over-year decrease of 183.33%.
Earnings History
Price & Consensus
Zacks News for MCRB
Seres Therapeutics (MCRB) Misses Q2 Earnings Estimates
MCRB: What are Zacks experts saying now?
Zacks Private Portfolio Services